It may not look like it on the basis of the last few quarters, but Agilent (NYSE:A) is getting better. Weakness in multiple test and measurement end-markets and lower government spending are generating stiff headwinds, but the company continues to roll out strong new products, and the long-term potential in chemical analysis and diagnostics remains impressive. Even though Agilent is near a 52-week high, I believe shareholders could still do reasonably well with this stock, particularly if their investment horizon is more than just a quarter or two.
Continue here:
http://www.investopedia.com/stock-analysis/081513/agilent-grinding-through-challenging-market-conditions-dhr-tmo-jdsu.aspx
Home
»
Abbott Labs
»
Agilent
»
Danaher
»
Investopedia
»
JDSU
»
Thermo Fisher
» Investopedia: Agilent Grinding Through Challenging Market Conditions
Thursday, August 15, 2013
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment